FrancophonIA/ELRC3.0 huggingface dataset:
English: BRAILLE Insulin Human Winthrop Comb 30
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Insulin Human Winthrop Comb 30
English: Based on your life-style and the results of your blood sugar (glucose) tests, your doctor will - determine how much Insulin Human Winthrop Comb 15 per day you will need, - tell you when to check your blood sugar level, and whether you need to carry out urine tests, - tell you when you may need to inject a higher or lower dose of Insulin Human Winthrop
Croatian: Na temelju Vašeg načina života i rezultata pretraga razine šećera (glukoze) u krvi, liječnik će: - odrediti koliko lijeka Insulin Human Winthrop Comb 15 Vam je dnevno potrebno, - Vam reći kada trebate provjeravati razinu šećera u krvi i trebate li napraviti pretrage mokraće, - Vam reći kada ćete možda trebati injicirati veću ili manju dozu lijeka Insulin Human Winthrop
English: To ensure you get the accurate dose, the Insulin Human Winthrop Basal cartridges are to be used only with the following pens: - JuniorSTAR which delivers doses in steps of 0.5 units - OptiPen, ClikSTAR, Tactipen, Autopen 24 or AllStar which deliver doses in steps of 1 unit.
Croatian: Kako bi se osigurala primjena ispravne doze, Insulin Human Winthrop Basal ulošci smiju se upotrebljavati samo sa sljedećim brizgalicama: - JuniorSTAR, kojim se lijek može dozirati u koracima od 0,5 jedinica - OptiPen, ClikSTAR, Tactipen, Autopen 24 ili AllStar, kojima se lijek može dozirati u koracima od 1 jedinice.
English: - The other ingredients are: protamine sulphate, metacresol, phenol, zinc chloride, sodium dihydrogen phosphate dihydrate, glycerol, sodium hydroxide (see section 2 “Important information about some of the ingredients of Insulin Human Winthrop Comb 15”), hydrochloric acid (for pH adjustment) and water for injections.
Croatian: - Drugi sastojci su: protaminsulfat, metakrezol, fenol, cinkov klorid, natrijev dihidrogenfosfat dihidrat, glicerol, natrijev hidroksid (vidjeti dio 2. "Važne informacije o nekim sastojcima lijeka Insulin Human Winthrop Comb 15"), kloridna kiselina (za podešavanje pH) i voda za injekcije.
English: NAME OF THE MEDICINAL PRODUCT Insulin Human Winthrop Infusat 100 IU/ml solution for injection in a cartridge
Croatian: NAZIV GOTOVOG LIJEKA Insulin Human Winthrop Infusat 100 IU/ml otopina za injekciju u bočici
English: NAME OF THE MEDICINAL PRODUCT Insulin Human Winthrop Rapid 100 IU/ml solution for injection in a cartridge
Croatian: NAZIV GOTOVOG LIJEKA Insulin Human Winthrop Rapid 100 IU/ml otopina za injekciju u bočici
English: Each pen contains 3 ml of solution for injection, equivalent to 300 IU insulin.
Croatian: Jedan uložak sadrži 3 ml otopine za injekciju, što odgovara 300 IU inzulina.
English: • Skin and allergic reactions Other mild reactions at the injection site (such as injection site redness, unusually intense pain on injection site, itching, injection site swelling or injection site inflammation) may occur.
Croatian: Opći poremećaji i reakcije na mjestu primjene reakcije na mjestu injiciranja urtikarija na mjestu injiciranja upala na mjestu injiciranja; bol na mjestu injiciranja; pruritus na mjestu injiciranja; eritem na mjestu injiciranja; oticanje na mjestu injiciranja;
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Insulin Human Winthrop Rapid 100 IU/ml solution for injection.
Croatian: NAZIV GOTOVOG LIJEKA I PUT(EVI) PRIMJENE LIJEKA Insulin Human Winthrop Rapid 100 IU/ml otopina za injekciju humani inzulin
English: you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage, you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever, you are taking or have taken certain other medicines (see section 2, "Other medicines and Insulin Human Winthrop Rapid").
Croatian: - ako niste injicirali inzulin ili ako niste injicirali dovoljno inzulina ili ako je učinkovitost inzulina smanjena, primjerice zbog nepravilnog čuvanja, - ako Vaša inzulinska brizgalica ne radi ispravno - ako vježbate manje nego obično, ako ste pod stresom (emocionalno uznemireni ili uzbuđeni) ili ako ste ozlijeđeni ili operirani, ako imate infekciju ili vrućicu, - ako uzimate ili ste uzimali neke druge lijekove (vidjeti dio 2. "Drugi lijekovi i Insulin Human Winthrop Rapid").
English: Insulin Human Winthrop Comb 50 must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Croatian: Insulin Human Winthrop Comb 50 ne smije se upotrijebiti ako se to ne može postići, tj. ako suspenzija, primjerice, ostane bistra ili ako se u inzulinu nalaze grudice, čestice ili pahuljice koje se mogu slijepiti za stijenke ili dno bočice.
English: Keep the pen in the outer carton in order to protect from light.
Croatian: Bočicu čuvati u vanjskom pakovanju radi zaštite od svjetlosti.
English: NAME OF THE MEDICINAL PRODUCT Insulin Human Winthrop Infusat 100 IU/ml solution for injection in a vial.
Croatian: NAZIV GOTOVOG LIJEKA Insulin Human Winthrop Basal 100 IU/ml suspenzija za injekciju u ulošku
English: BRAILLE Insulin Human Winthrop Basal
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Insulin Human Winthrop Basal
English: Examples include: you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage, your insulin pen does not work properly, you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever, you are taking or have taken certain other medicines (see section 2, "Other medicines and Insulin Human Winthrop Comb 30").
Croatian: Primjeri: - ako niste injicirali inzulin ili ako niste injicirali dovoljno inzulina ili ako je učinkovitost inzulina smanjena, primjerice zbog nepravilnog čuvanja, - ako vježbate manje nego obično, ako ste pod stresom (emocionalno uznemireni ili uzbuđeni) ili ako ste ozlijeđeni ili operirani, ako imate infekciju ili vrućicu, - ako uzimate ili ste uzimali neke druge lijekove (vidjeti dio 2. "Drugi lijekovi i Insulin Human Winthrop Comb 30").
English: Examples include: you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage, your insulin pump does not work properly, you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever, you are taking or have taken certain other medicines (see section 2, "Other medicines and Insulin Human Winthrop Infusat").
Croatian: Primjeri: - ako niste injicirali inzulin ili ako niste injicirali dovoljno inzulina ili ako je učinkovitost inzulina smanjena, primjerice zbog nepravilnog čuvanja, - ako Vam inzulinska pumpa ne radi ispravno, - ako vježbate manje nego obično, ako ste pod stresom (emocionalno uznemireni ili uzbuđeni) ili ako ste ozlijeđeni ili operirani, ako imate infekciju ili vrućicu, - ako uzimate ili ste uzimali neke druge lijekove (vidjeti dio 2. "Drugi lijekovi i Insulin Human
English: Pens to be used with Insulin Human Winthrop Comb 30 cartridges The Insulin Human Winthrop Comb 30 cartridges should only be used with the following pens: - JuniorSTAR which delivers Insulin Human Winthrop Comb 30 in 0.5 unit dose increments - OptiPen, ClikSTAR, Tactipen, Autopen 24 and AllStar which all deliver Insulin Human Winthrop Comb 30 in 1 unit dose increments.
Croatian: Brizgalice koje se moraju koristiti s Insulin Human Winthrop Comb 30 ulošcima Insulin Human Winthrop Comb 30 ulošci smiju se upotrebljavati samo sa sljedećim brizgalicama: - JuniorSTAR, kojim se može dozirati lijek Insulin Human Winthrop Comb 30 u koracima od 0,5 jedinica
English: Examples include: you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage, your insulin pen does not work properly, you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever, you are taking or have taken certain other medicines (see section 2, "Other medicines and Insulin Human Winthrop comb 15").
Croatian: Primjeri: - ako niste injicirali inzulin ili ako niste injicirali dovoljno inzulina ili ako je učinkovitost inzulina smanjena, primjerice zbog nepravilnog čuvanja, - ako vježbate manje nego obično, ako ste pod stresom (emocionalno uznemireni ili uzbuđeni) ili ako ste ozlijeđeni ili operirani, ako imate infekciju ili vrućicu, - ako uzimate ili ste uzimali neke druge lijekove (vidjeti dio 2. "Drugi lijekovi i Insulin Human Winthrop Comb 15").
English: MARKETING AUTHORISATION NUMBER(S) EU/1/06/368/009 (1 vial of 10 ml) EU/1/06/368/010 (5 vials of 10 ml)
Croatian: 12. BROJEVI ODOBRENJA ZA STAVLJANJE GOTOVOG LIJEKA U PROMET EU/1/06/368/009 (1 bočica od 10 ml)
English: Opened vials
Croatian: Otvorene bočice
English: MARKETING AUTHORISATION NUMBER(S) EU/1/06/368/047 (1 vial of 5 ml) EU/1/06/368/048 (5 vials of 5 ml)
Croatian: 12. BROJEVI ODOBRENJA ZA STAVLJANJE GOTOVOG LIJEKA U PROMET EU/1/06/368/047 (1 bočica od 5 ml)
English: Nederland sanofi-aventis Netherlands B.V. Tel: +31 (0)182 557 755
Croatian: България sanofi-aventis Bulgaria EOOD Тел.: +359 (0)2 970 53 00
English: Based on your life-style and the results of your blood sugar (glucose) tests, your doctor will - determine how much Insulin Human Winthrop Basal per day you will need, - tell you when to check your blood sugar level, and whether you need to carry out urine tests, - tell you when you may need to inject a higher or lower dose of Insulin Human Winthrop Basal.
Croatian: Na temelju Vašeg načina života i rezultata pretraga razine šećera (glukoze) u krvi, liječnik će: - odrediti koliko lijeka Insulin Human Winthrop Basal Vam je dnevno potrebno, - Vam reći kada trebate provjeravati razinu šećera u krvi i trebate li napraviti pretrage mokraće, - Vam reći kada ćete možda trebati injicirati veću ili manju dozu lijeka Insulin Human Winthrop
English: Polska sanofi-aventis Sp .
Croatian: Nederland sanofi-aventis Netherlands B.V.
English: EU/1/06/368/134 EU/1/06/368/135 EU/1/06/368/136
Croatian: EU/1/06/368/131 EU/1/06/368/132 EU/1/06/368/133 EU/1/06/368/134 EU/1/06/368/135 EU/1/06/368/136
English: A response is usually seen in two to four weeks.
Croatian: Odgovor se najčešće može uočiti u roku od dva do četiri tjedna.
English: The response to treatment should be assessed regularly.
Croatian: Redovito treba ocjenjivati odgovor na liječenje.
English: • major depression;
Croatian: • teškim depresivnim poremećajem;
English: Neurotransmitters are chemicals that allow nerve cells to communicate with one another.
Croatian: Neurotransmiteri su kemikalije koje omogućuju živcima međusobnu komunikaciju.
English: Treatment must not be started in patients with uncontrolled hypertension (high blood pressure), because of a risk of hypertensive crisis (sudden, dangerously high blood pressure).
Croatian: Liječenje se ne smije započeti u bolesnika s nekontroliranom hipertenzijom (visokim krvnim tlakom), uslijed rizika od hipertenzivne krize (iznenadno, opasno visokog krvnog tlaka).
English: The main measure of effectiveness was the change in the severity of pain each week.
Croatian: Glavno mjerilo djelotvornosti bila je tjedna promjena u jačini boli.
English: In both studies, pain reduction was seen from the first week of treatment for up to 12 weeks.
Croatian: U oba ispitivanja smanjenje boli uočeno je od prvog tjedna liječenja do 12. tjedna.
English: Since these neurotransmitters are involved in maintaining high mood and reducing the sensation of pain, blocking their re-uptake into nerve cells can improve the symptoms of depression, anxiety and neuropathic pain.
Croatian: Budući da su ovi neurotransmiteri uključeni u održavanje dobrog raspoloženja i smanjenje osjećaja boli, inhibirajući njihovu ponovnu pohranu u živčanim stanicama mogu se poboljšati simptomi depresije, anksioznosti i neuropatične boli.
English: Most patients will need to take 60 mg per day.
Croatian: Većina bolesnika treba uzeti 60 mg na dan.
English: The full EPAR and risk management plan summary for Duloxetine Lilly can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR kao i sažetak plana upravljanja rizikom za lijek Duloxetine Lilly nalaze se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This prevents the active substance being destroyed by the acid in the stomach.
Croatian: Na taj se način sprječava razgradnja djelatne tvari u želucu.
English: The most common side effects with Duloxetine Lilly (which may affect more than 1 in 10 people) are nausea (feeling sick), headache, dry mouth, somnolence (sleepiness) and dizziness.
Croatian: Najčešće nuspojave lijeka Duloxetine Lilly (mogu se javiti u više od 1 na 10 osoba) su mučnina (osjećaj slabosti), glavobolja, suha usta, somnolencija (nesanica) i vrtoglavica.
English: Most of these are mild or moderate, starting early in treatment and getting milder as treatment continues.
Croatian: Većina je tih nuspojava blaga ili umjerena, pojavljuju se rano u liječenju i slabe kako terapija napreduje.
English: Four studies looked at the treatment of the disorder by measuring the reduction in symptoms after nine to 10 weeks.
Croatian: Četiri ispitivanja su istražila liječenje poremećaja tako što je izmjereno smanjenje simptoma nakon devet do deset tjedana.
English: • generalised anxiety disorder (long-term anxiety or nervousness about everyday matters).
Croatian: • s generaliziranim anksioznim poremećajem (kronična anksioznost ili nervoza vezana uz svakodnevnicu).
English: Duloxetine Lilly is a medicine that is used to treat adults with the following diseases:
Croatian: Duloxetine Lilly je lijek koji se koristi za liječenje odraslih osoba sa sljedećim bolestima:
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555
Croatian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
English: This medicine contains the active substance duloxetine and is the same as Cymbalta, which is already authorised in the European Union (EU).
Croatian: Ovaj lijek sadrži djelatnu tvar duloksetin, te je isti kao Cymbalta, koji je već odobren za primjenu u Europskoj uniji (EU).
English: Duloxetine Lilly must not be used together with monoamine oxidase inhibitors (another group of antidepressants), fluvoxamine (another antidepressant), or ciprofloxacin or enoxacin (types of antibiotics).
Croatian: Duloxetine Lilly se ne smije koristiti zajedno s inhibitorima monoaminooksidaze (drugom grupom antidepresiva), fluvoksamin (drugi antidepresiv) ili ciprofloksacinom ili enoksacinom (tipovi antibiotika).
English: It works by preventing the neurotransmitters 5-hydroxytryptamine (also called serotonin) and noradrenaline from being taken back up into nerve cells in the brain and spinal cord.
Croatian: Djeluje sprječavajući ponovnu pohranu neurotransmitora 5-hidroksitriptamina (koji se također zove serotonin) i noradrenalina u živčane stanice u mozgu i kralješničnoj moždini.
English: • pain due to diabetic peripheral neuropathy (damage to the nerves in the extremities that can occur in patients with diabetes);
Croatian: • boli uslijed dijabetičke periferne neuropatije (oštećenja živaca u ekstremitetima koja mogu nastupiti u bolesnika s dijabetesom);
English: By blocking their re-uptake, duloxetine increases the amount of these neurotransmitters in the spaces between these nerve cells, increasing the level of communication between the cells.
Croatian: Inhibirajući njihovu ponovnu pohranu duloksetin povećava količinu tih neurotransmitera u prostorima između živčanih stanica povećavajući razinu komunikacije između stanica.
English: For generalised anxiety disorder, the recommended starting dose is 30 mg once a day, but the dose can be increased to 60, 90 or 120 mg depending on the patient's response.
Croatian: U slučaju generaliziranog anksioznog poremećaja preporučena početna doza iznosi 30 mg jednom na dan, no doza se može povećati na 60, 90 ili 120 mg ovisno o odgovoru bolesnika.
English: Patients who also have major depression should start with 60 mg once a day.
Croatian: Bolesnici s teškim depresivnim poremećajem trebaju također započeti s dozom od 60 mg jednom na dan.
English: The company that makes Cymbalta has agreed that its scientific data can be used for Duloxetine Lilly (‘informed consent').
Croatian: Proizvođač lijeka Cymbalta suglasan je da se znanstveni podaci koriste za lijek Duloxetine Lilly („informirani pristanak”).
English: Six of the studies looked at the treatment of depression and measured the change in symptoms over up to six months.
Croatian: Šest ispitivanja istražilo je liječenje depresije i izmjerilo je promjenu u simptomima tijekom razdoblja od šest mjeseci.
English: The fifth study looked at how long it took for symptoms to return in 429 patients who had initially responded to Duloxetine Lilly.
Croatian: Peto je ispitivanje istražilo koliko je vremena prošlo do ponovnog pojavljivanja simptoma u 429 bolesnika koji su prvotno odgovorili na liječenje lijekom Duloxetine Lilly.
English: Duloxetine Lilly duloxetine
Croatian: Duloxetine Lilly duloksetin
English: This is a summary of the European public assessment report (EPAR) for Duloxetine Lilly.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Duloxetine Lilly.
English: Duloxetine Lilly must also not be used in patients with reduced liver function or patients with severely reduced kidney function.
Croatian: Duloxetine Lilly se također ne smije koristiti u bolesnika sa smanjenom funkcijom jetre ili bolesnika s ozbiljno smanjenom funkcijom bubrega.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Duloxetine Lilly's benefits are greater than its risks and recommended that it be approved for use in the EU.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji odlučio je da koristi od lijeka Duloxetine Lilly nadmašuju s njim povezane rizike te je preporučio njegovo odobrenje za korištenje u Europskoj uniji.
English: The dose of Duloxetine Lilly should be reduced gradually when stopping treatment.
Croatian: Dozu lijeka Duloxetine Lilly treba postupno smanjivati prilikom prestanka liječenja.
English: For major depression, the recommended dose of Duloxetine Lilly is 60 mg once a day.
Croatian: U slučaju teškog depresivnog poremećaja preporučena doza lijeka Duloxetine Lilly iznosi 60 mg jednom na dan.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Duloxetine Lilly, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka kao i u uputi o lijeku za lijek Duloxetine Lilly nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: It is not intended to provide practical advice on how to use Duloxetine Lilly.
Croatian: Svrha sažetka nije davati praktične savjete o korištenju lijeka Duloxetine Lilly.
English: For diabetic neuropathic pain, the recommended dose is 60 mg per day but some patients may need a higher dose of 120 mg per day.
Croatian: U slučaju dijabetičke periferne neuropatije preporučena doza iznosi 60 mg na dan, no pojedinim bolesnicima može biti potrebna doza veća od 120 mg na dan.
English: The active substance in this medicine, duloxetine, is a serotonin-noradrenaline re-uptake inhibitor.
Croatian: Djelatna tvar lijeka, duloksetin, inhibitor je ponovne pohrane noradrenalina.
English: The other two studies looked at how long it took for symptoms to return in patients who had initially responded to Duloxetine Lilly, including 288 patients with a history of repeated episodes of depression for up to five years.
Croatian: Druga dva ispitivanja istražila su koliko je vremena bilo potrebno da se simptomi ponovno pojave u bolesnika koji su prvotno odgovorili na liječenje lijekom Duloxetine Lilly, te su uključila 288 bolesnika s anamnezom ponovljenih epizoda depresije u razdoblju do pet godina.
English: What is Duloxetine Lilly and what is it used for?
Croatian: Što je Duloxetine Lilly i za što se koristi?
English: What measures are being taken to ensure the safe and effective use of Duloxetine Lilly?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Duloxetine Lilly?
English: For more information about treatment with Duloxetine Lilly, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Duloxetine Lilly pročitajte u uputi o lijeku (također dio EPAR-a), ili se obratite svom liječniku ili ljekarniku.
English: It also took longer for symptoms to return in patients taking Duloxetine Lilly than in those taking placebo.
Croatian: Također je dulje trajalo da se simptomi ponovno pojave u bolesnika koji su uzimali lijek Duloxetine Lilly u odnosu na razdoblje u bolesnika koji su uzimali placebo.
English: In patients who respond to Duloxetine Lilly, treatment should continue for several months to prevent the disease coming back, or for longer in patients who have had repeated periods of depression in the past.
Croatian: U bolesnika koji su odgovorili na lijek Duloxetine Lilly, liječenje treba nastaviti tijekom nekoliko mjeseci kako bi se spriječio relaps bolesti ili tijekom duljeg razdoblja u slučaju bolesnika koji su imali ponovljena razdoblja depresije u prošlosti.
English: In the two studies where the approved dose of Duloxetine Lilly was compared with placebo, Duloxetine Lilly was more effective.
Croatian: U dva ispitivanja, u kojima je odobrena doza lijeka Duloxetine Lilly uspoređena s placebom, Duloxetine Lilly je bio djelotvorniji.
English: For neuropathic pain, Duloxetine Lilly has been compared with placebo in two 12-week studies in 809 diabetic adults.
Croatian: U slučaju neuropatične boli Duloxetine Lilly je uspoređen s placebom u dva 12-tjedna ispitivanja u 809 odraslih dijabetičara.
English: Other information about Duloxetine Lilly
Croatian: Ostale informacije o lijeku Duloxetine Lilly
English: Duloxetine Lilly was shown to be more effective than placebo at treating the disorder and preventing symptoms returning.
Croatian: Utvrđeno je da je Duloxetine Lilly djelotvorniji od placeba u liječenju poremećaja i sprječavanju ponovnog pojavljivanja simptoma.
English: A risk management plan has been developed to ensure that Duloxetine Lilly is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Duloxetine Lilly.
English: What are the risks associated with Duloxetine Lilly?
Croatian: Koji su rizici povezani s lijekom Duloxetine Lilly?
English: Why is Duloxetine Lilly approved?
Croatian: Zašto je Duloxetine Lilly odobren?
English: For generalised anxiety disorder, Duloxetine Lilly has been compared with placebo in five studies involving a total of 2,337 patients.
Croatian: U slučaju općeg anksioznog poremećaja lijek Duloxetine Lilly uspoređen je s placebom u pet ispitivanja koja su obuhvatila ukupno 2 337 bolesnika.
English: Although the results of the depression studies varied, Duloxetine Lilly was more effective than placebo in four of the studies.
Croatian: Iako su rezultati ispitivanja depresije varirali, Duloxetine Lilly je bio djelotvorniji od placeba u četiri ispitivanja.
English: These studies showed that Duloxetine Lilly was more effective at reducing pain than placebo.
Croatian: Ta su ispitivanja pokazala da je Duloxetine Lilly bio djelotvorniji u smanjivanju boli u odnosu na placebo.